Retatrutide, from Soma Chems , is gaining considerable attention as a potential treatment for obesity control soma chems retatrutide . This dual-action medication integrates the properties of a GLP-1 receptor agonist and a GIP receptor activator , aiming to not only promote metabolic improvements but also improve associated metabolic conditions . P